Page 96 - AN-4-2
P. 96

Advanced Neurology                                                   PVT in Indonesian neurological patients



            per subgroup for determining specificity.  There were no   analyzed using the Spearman correlation due to their non-
                                             37
            missing data in this study. Demographic variables (age,   normal distribution.  The effect size was determined using
                                                                               44
            education, and gender) were compared between groups.   r, with r = 0.10 indicating a small effect, r = 0.30 indicating
            MMSE scores in the ND and PS groups were calculated   a medium effect, and r = 0.50 indicating a large effect.
                                                                                                            39
            and compared. The mean PVT scores for each group   The data are available through the Donders repository.
            were compared using the Kruskal–Wallis test due to the   Analyses were performed using JASP 0.16.3. 45
            non-normal distribution of all PVTs across the groups
            (Shapiro–Wilk  P < 0.05),  followed by  post hoc Mann–  3. Results
                                 38
            Whitney  U-tests  with  Bonferroni  correction and their   As shown in Table 1, significant differences were observed
            corresponding effect sizes (r). 39,40  In addition, participants   between the clinical groups in terms of age. As expected,
            with ND were divided into mild (MMSE score ≥22) and   the ND group was the oldest and had a significantly lower
            major (MMSE score <22) ND groups,  as distinct PVT cut-  MMSE score than the PS group. No significant differences
                                         41
            off scores might apply to these groups. Diagnostic accuracy   were found between the clinical groups regarding
            was evaluated in each group by examining the specificity   educational level and gender distribution, although the
            of the recommended cut-off scores from a previous   ND group had a slightly lower educational level compared
            simulation study.  Participants who performed below the   to the other two groups. The clinical groups also differed
                          22
            specific cut-off score were considered false positives. If the   significantly on all PVT scores, as shown in Table 2. The
            obtained specificity was below the acceptable threshold   ND group performed significantly worse than the other
            (<0.90), the cut-off scores were adjusted (i.e., lowered) to   clinical groups on all PVTs, except for the RDS, with
            ensure a specificity rate of at least 0.90, as higher specificity   medium-to-large effects (r range = 0.29 – 0.55; Table 3).
            is essential for PVTs. 14,42,43  For the NV-MSVT, the specificity   No significant differences were found between the PVT
            rate was calculated by dividing the number of participants   scores of the PS and mixed-etiology groups. In addition,
            failing at least one of the A criteria and at least two of the   the mild ND group scored significantly higher than the
            B criteria (indicating probable invalid performance) by the   major ND group on all PVTs, with medium to medium-
            total number of participants in each group, as suggested by   to-large effects (r range = 0.38 – 0.50; Table 4).
            the NV-MSVT manual. 26
                                                                 The results presented in Table 5 indicate that the cut-
              The adjusted cut-off scores for each PVT were used to   off scores from the previous simulation study resulted in
            calculate the number of participants failing at least two   unacceptably low specificity rates (<0.90) for all PVTs.
            PVTs. Failure on the embedded validities of DS (e.g., failure   Therefore, we adjusted the cut-off scores for use in clinical
            on RDS and LDF-2) was considered a single PVT failure,   samples.  For the RDS,  LDF-1, and LDF-2,  the PS and
            as they are derived from the same test,  as reflected by   mixed-etiology groups achieved specificity rates of at least
                                            13
            their high intercorrelation in this study. The demographic   0.90 using the adjusted cut-off scores of ≤4, ≤3, and ≤2,
            characteristics of the participants failing at least two PVTs   respectively. A  more significant adjustment of the cut-
            were then presented.                               off scores in the RDS, LDF-1, and LDF-2 was required
              Intercorrelation analyses were performed between   for the ND group, with cut-off scores decreased to ≤3,
            PVT scores, demographic variables (i.e., gender, age, and   ≤2, and ≤1, respectively. However, similar to the PS and
            education), and MMSE scores (for participants with ND   mixed-etiology groups, the adjusted cut-off score for the
            and PS groups only). The point-biserial correlation was   LDF-2 in the mild ND group was ≤2. For the TMJPI, the
            used for the gender variable, while the other variables were   mixed-etiology group required the least adjustment to

            Table 2. Comparison of performance validity test scores between clinical groups
            Statistical   RDS         LDF‑1          LDF‑2          TMJPI                 NV‑MSVT
            parameter                                                             Criterion A1   Criterion A2

                     ND   PS  Mix  ND   PS  Mix  ND    PS  Mix  ND    PS   Mix  ND   PS   Mix  ND    PS  Mix
            Mean     5.98 6.76 6.81  4.18  4.71  4.92  3.37  4.00  4.04  81.47  86.74  87.23  79.83  91.24  91.34  81.51  90.12  88.98
            SD       1.82 1.48 1.78  1.22  0.74  1.12  1.22  0.94  1.00  9.63  5.41  6.03  16.08  9.95  10.89  13.88  11.27  14.94
            H            7.97*         10.89*         9.30*         25.65***        21.35***       15.59***
            Notes: *P<0.05; ***P<0.001.
            Abbreviations: H: Kruskal-Wallis index; LDF-1: Longest digit forward-1 trial; LDF-2: Longest digit forward-2 trials; Mix: Mixed-etiology group; ND:
            Neurocognitive disorder due to possible neurodegenerative disease group; NV-MSVT: Non-verbal medical symptom validity test; PS: Post-stroke
            group; RDS: Reliable digit span; SD: Standard deviation; TMJPI: Tes Memori Jangka Pendek Indonesia.


            Volume 4 Issue 2 (2025)                         90                               doi: 10.36922/an.5661
   91   92   93   94   95   96   97   98   99   100   101